Healthcare · Industry
Biotechnology - List & Prices (656 stocks)
| Company | Ticker | Price | Mkt cap | P/E | Div yield |
|---|---|---|---|---|---|
| Plus Therapeutics, Inc. | PSTV | $3.84 Aug 7, 2026 | $26.64M | 0.2 | — |
| TScan Therapeutics, Inc. | TCRX | $0.39 | $26.54M | — | |
| ABVC BioPharma, Inc. | ABVC | $0.96 | $25.59M | — | |
| Tvardi Therapeutics, Inc. | TVRD | $1.91 | $25.48M | — | |
| BeyondSpring Inc. | BYSI | $0.62 | $25.42M | — | |
| Atossa Therapeutics, Inc. | ATOS | $2.52 | $25.15M | — | |
| Lantern Pharma Inc. | LTRN | $1.91 | $24.35M | — | |
| Jasper Therapeutics, Inc. | JSPR | $0.71 | $23.58M | — | |
| Lexaria Bioscience Corp. | LEXX | $14.15 | $23.38M | — | |
| GridAI Technologies Corp. | GRDX | $3.25 | $23.18M | — | |
| Palatin Technologies, Inc. | PTN | $12.70 | $22.60M | 115.5 | — |
| Allarity Therapeutics, Inc. | ALLR | $1.42 | $22.59M | — | |
| Cellectar Biosciences, Inc. | CLRB | $2.37 | $22.40M | — | |
| Akari Therapeutics, Plc | AKTX | $11.47 | $22.33M | — | — |
| Sensei Biotherapeutics, Inc. | SNSE | $25.96 Jul 17, 2026 | $22.10M | — | |
| Cocrystal Pharma, Inc. | COCP | $1.13 | $21.77M | — | |
| Longeveron Inc. | LGVN | $6.81 | $21.71M | — | |
| Cerenome, Inc. | CNSY | $2.76 | $20.91M | 1.0 | — |
| Adial Pharmaceuticals, Inc. | ADIL | $7.12 | $20.89M | — | |
| Dyadic International, Inc. | DYAI | $0.52 | $20.84M | — | |
| Quantum BioPharma Ltd. | QNTM | $3.24 | $20.83M | — | |
| Neuphoria Therapeutics Inc. | NEUP | $3.77 | $20.38M | — | |
| Lipocine Inc. | LPCN | $2.45 | $20.20M | — | |
| Cyclerion Therapeutics, Inc. | CYCN | $4.25 | $19.90M | — | |
| Chemomab Therapeutics Ltd. | CMMB | $2.71 | $19.86M | — | |
| Marker Therapeutics, Inc. | MRKR | $1.18 | $19.67M | — | |
| Pasithea Therapeutics Corp. | KTTA | $0.58 | $19.38M | — | |
| NewcelX Ltd. | NCEL | $3.35 | $19.35M | — | |
| NeuroSense Therapeutics Ltd. | NRSN | $0.51 | $19.29M | — | |
| Enlivex Ltd. | ENLV | $1.10 | $19.23M | 0.0 | — |
| VYNE Therapeutics Inc. | VYNE | $28.56 Jul 27, 2026 | $19.07M | — | |
| Tempest Therapeutics, Inc. | TPST | $1.03 | $17.04M | — | |
| BioVie Inc. | BIVI | $2.00 | $16.90M | — | |
| BioCardia, Inc. | BCDA | $1.08 | $16.35M | — | |
| Pluri Inc. | PLUR | $1.36 | $16.31M | — | |
| Citius Pharmaceuticals, Inc. Common Stock | CTXR | $0.59 | $16.13M | — | |
| Vyome Holdings, Inc. | HIND | $2.22 | $15.58M | — | |
| Passage Bio, Inc. | PASG | $4.65 | $14.96M | — | |
| Lisata Therapeutics, Inc. | LSTA | $1.65 | $14.87M | — | |
| Applied Therapeutics, Inc. | APLT | $0.10 Feb 4, 2026 | $14.86M | — | |
| CalciMedica, Inc. | CALC | $2.17 | $14.82M | — | |
| Anebulo Pharmaceuticals, Inc. | ANEB | $0.36 | $14.64M | — | |
| Quoin Pharmaceuticals, Ltd. | QNRX | $7.26 | $14.58M | — | |
| Immuron Limited American Depositary Shares | IMRN | $1.80 | $14.53M | — | |
| Synlogic, Inc. | SYBX | $1.17 | $14.33M | — | |
| Daré Bioscience, Inc. | DARE | $0.72 | $13.97M | — | |
| Moleculin Biotech, Inc. | MBRX | $0.71 | $13.83M | 0.1 | — |
| Hoth Therapeutics, Inc. | HOTH | $0.82 Jul 17, 2026 | $13.55M | — | |
| Intensity Therapeutics, Inc. | INTS | $4.10 | $13.39M | — | |
| SeaStar Medical Holding Corporation | ICU | $2.98 | $13.13M | — |
Plus Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $26.64M
- P/E
- 0.2
TScan Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $26.54M
- P/E
- unprofitable
ABVC BioPharma, Inc.
Healthcare / Biotechnology
- Market Cap
- $25.59M
- P/E
- unprofitable
Tvardi Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $25.48M
- P/E
- unprofitable
BeyondSpring Inc.
Healthcare / Biotechnology
- Market Cap
- $25.42M
- P/E
- unprofitable
Atossa Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $25.15M
- P/E
- unprofitable
Lantern Pharma Inc.
Healthcare / Biotechnology
- Market Cap
- $24.35M
- P/E
- unprofitable
Jasper Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $23.58M
- P/E
- unprofitable
Lexaria Bioscience Corp.
Healthcare / Biotechnology
- Market Cap
- $23.38M
- P/E
- unprofitable
GridAI Technologies Corp.
Healthcare / Biotechnology
- Market Cap
- $23.18M
- P/E
- unprofitable
Palatin Technologies, Inc.
Healthcare / Biotechnology
- Market Cap
- $22.60M
- P/E
- 115.5
Allarity Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $22.59M
- P/E
- unprofitable
Cellectar Biosciences, Inc.
Healthcare / Biotechnology
- Market Cap
- $22.40M
- P/E
- unprofitable
Akari Therapeutics, Plc
Healthcare / Biotechnology
- Market Cap
- $22.33M
Sensei Biotherapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $22.10M
- P/E
- unprofitable
Cocrystal Pharma, Inc.
Healthcare / Biotechnology
- Market Cap
- $21.77M
- P/E
- unprofitable
Longeveron Inc.
Healthcare / Biotechnology
- Market Cap
- $21.71M
- P/E
- unprofitable
Cerenome, Inc.
Healthcare / Biotechnology
- Market Cap
- $20.91M
- P/E
- 1.0
Adial Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $20.89M
- P/E
- unprofitable
Dyadic International, Inc.
Healthcare / Biotechnology
- Market Cap
- $20.84M
- P/E
- unprofitable
Quantum BioPharma Ltd.
Healthcare / Biotechnology
- Market Cap
- $20.83M
- P/E
- unprofitable
Neuphoria Therapeutics Inc.
Healthcare / Biotechnology
- Market Cap
- $20.38M
- P/E
- unprofitable
Lipocine Inc.
Healthcare / Biotechnology
- Market Cap
- $20.20M
- P/E
- unprofitable
Cyclerion Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $19.90M
- P/E
- unprofitable
Chemomab Therapeutics Ltd.
Healthcare / Biotechnology
- Market Cap
- $19.86M
- P/E
- unprofitable
Marker Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $19.67M
- P/E
- unprofitable
Pasithea Therapeutics Corp.
Healthcare / Biotechnology
- Market Cap
- $19.38M
- P/E
- unprofitable
NewcelX Ltd.
Healthcare / Biotechnology
- Market Cap
- $19.35M
- P/E
- unprofitable
NeuroSense Therapeutics Ltd.
Healthcare / Biotechnology
- Market Cap
- $19.29M
- P/E
- unprofitable
Enlivex Ltd.
Healthcare / Biotechnology
- Market Cap
- $19.23M
- P/E
- 0.0
VYNE Therapeutics Inc.
Healthcare / Biotechnology
- Market Cap
- $19.07M
- P/E
- unprofitable
Tempest Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $17.04M
- P/E
- unprofitable
BioVie Inc.
Healthcare / Biotechnology
- Market Cap
- $16.90M
- P/E
- unprofitable
BioCardia, Inc.
Healthcare / Biotechnology
- Market Cap
- $16.35M
- P/E
- unprofitable
Pluri Inc.
Healthcare / Biotechnology
- Market Cap
- $16.31M
- P/E
- unprofitable
Citius Pharmaceuticals, Inc. Common Stock
Healthcare / Biotechnology
- Market Cap
- $16.13M
- P/E
- unprofitable
Vyome Holdings, Inc.
Healthcare / Biotechnology
- Market Cap
- $15.58M
- P/E
- unprofitable
Passage Bio, Inc.
Healthcare / Biotechnology
- Market Cap
- $14.96M
- P/E
- unprofitable
Lisata Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $14.87M
- P/E
- unprofitable
Applied Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $14.86M
- P/E
- unprofitable
CalciMedica, Inc.
Healthcare / Biotechnology
- Market Cap
- $14.82M
- P/E
- unprofitable
Anebulo Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $14.64M
- P/E
- unprofitable
Quoin Pharmaceuticals, Ltd.
Healthcare / Biotechnology
- Market Cap
- $14.58M
- P/E
- unprofitable
Immuron Limited American Depositary Shares
Healthcare / Biotechnology
- Market Cap
- $14.53M
- P/E
- unprofitable
Synlogic, Inc.
Healthcare / Biotechnology
- Market Cap
- $14.33M
- P/E
- unprofitable
Daré Bioscience, Inc.
Healthcare / Biotechnology
- Market Cap
- $13.97M
- P/E
- unprofitable
Moleculin Biotech, Inc.
Healthcare / Biotechnology
- Market Cap
- $13.83M
- P/E
- 0.1
Hoth Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $13.55M
- P/E
- unprofitable
Intensity Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $13.39M
- P/E
- unprofitable
SeaStar Medical Holding Corporation
Healthcare / Biotechnology
- Market Cap
- $13.13M
- P/E
- unprofitable
Showing 501–550 of 656 · ranked by market capitalization
Where the trailing year was a loss, P/E appears as “unprofitable”; a dash is missing data.